This Week in Cardiology

• Jan 13 2023 This Week in Cardiology   FOURIER authors' response, a possible practice-changing paper in electrophysiology, and the ATLAS and CAPLA trials are the topics John Mandrola, MD, discusses in this week’s podcast.
  theheart.org on Medscape, January 13, 2023
• Jan 6 2023 This Week in Cardiology   Damar Hamlin, obesity and semaglutide, Open Data and PCSK9 inhibitors, and TAVI vs SAVR trials are the topics John Mandrola, MD, discusses in this week’s podcast.
  theheart.org on Medscape, January 06, 2023
• Dec 23 2022 This Week in Cardiology   The top ten stories of the year plus a few honorary mentions.
  theheart.org on Medscape, December 23, 2022
• Dec 16 2022 This Week in Cardiology   BP control over the long term, omecamtiv mecarbil, incentives and Goodhart’s law, and open science are the topics John Mandrola, MD, covers in this week’s podcast.
  theheart.org on Medscape, December 16, 2022
• Dec 9 2022 This Week in Cardiology   Nudges, statins, AI, less-is-more in the ICU, myocarditis, exercise as medicine, and December in the hospital are the topics John Mandrola, MD, covers in this week’s podcast.
  theheart.org on Medscape, December 09, 2022
• Dec 2 2022 This Week in Cardiology   SGLT2 inhibitors, publishing choices, second and third order effects of interventions, decision support, and patient selection for preventive procedures are the topics John Mandrola, MD, discusses in this week’s podcast.
  theheart.org on Medscape, December 02, 2022
• Nov 18 2022 This Week in Cardiology   AHA 2022, Part 2: IRONMAN, ECMO-CS, CTS-AMI, and PROGRESSIVE AF are the trials John Mandrola, MD, reviews in this week’s podcast.
  theheart.org on Medscape, November 18, 2022
• Nov 11 2022 This Week in Cardiology   AHA 2022 Part 1: ISCHEMIA-EXTEND, STRONG-HF, chlorthalidone vs HCTZ, experts vs practitioners; torsemide vs furosemide; and TG lowering are discussed by John Mandrola, MD, in this week’s podcast.
  theheart.org on Medscape, November 11, 2022
• Nov 4 2022 This Week in Cardiology   AF conversion in the ED, HRT, a shining example of evidence-based medicine and less-is-more, multimorbidity, and what’s coming at AHA are the topics John Mandrola, MD, covers in this week’s podcast.
  theheart.org on Medscape, November 04, 2022
• Oct 28 2022 This Week in Cardiology   ERASE AF follow-up, recreational drugs and AF, etripamil, misuse of science, and diabetes as a cardiovascular risk factor are the topics John Mandrola, MD, discusses in this week's podcast.
  theheart.org on Medscape, October 28, 2022
• Oct 21 2022 This Week in Cardiology   The ERASE AF ablation trial, left bundle pacing, finerenone, and perceptions of cardiology are the topics John Mandrola, MD, discusses in this week’s podcast.
  theheart.org on Medscape, October 21, 2022
• Oct 14 2022 This Week in Cardiology  
  theheart.org on Medscape, October 14, 2022
• Oct 7 2022 This Week in Cardiology   Post-PCI antiplatelet therapy, palliative care in patients with HF, Watchman information on hospital websites, and HCM in athletes are the topics John Mandrola, MD, covers in this week's podcast.
  theheart.org on Medscape, October 07, 2022
• Sep 30 2022 This Week in Cardiology   Pulmonary embolism, coffee, when DOACs don’t work, lipoprotein (a), and the marginal benefits of current CV therapy are the topics John Mandrola, MD, discusses in this week’s podcast.
  theheart.org on Medscape, September 30, 2022
• Sep 23 2022 This Week in Cardiology   The PROTECTED TAVR trial of an embolic protection device, renal denervation for hypertension, percutaneouls left atrial appendage closure, and deprescribing aspirin are discussed in this weeks podcast.
  theheart.org on Medscape, September 23, 2022
• Sep 16 This Week in Cardiology   The safety of very low LDL-C, the win-ratio analytic method, sacubitril/valsartan, SGLT2 inhibitors, and percutaneous left atrial appendage closure are discussed in this week’s podcast.
  theheart.org on Medscape, September 16, 2022
• Sep 9 2022 This Week in Cardiology   A potential new anticoagulant, surveillance stress testing, a trial misinterpretation, an old diuretic, and AI in cardiology are the topics John Mandrola, MD, discusses in this week’s podcast.
  theheart.org on Medscape, September 09, 2022
• Sep 2 2022 This Week in Cardiology   A second ESC review covering REVIVED, the DANCAVAS CV screening trial, DELIVER on dapagliflozin in HF with mildly reduced EF, and the INVICTUS trial of rivaroxaban in rheumatic heart disease.
  theheart.org on Medscape, September 02, 2022
• Aug 26 2022 This Week in Cardiology   Early rhythm control in AF, treating coronary artery disease before transcatheter aortic valve implantation, and an ESC 2022 preview are the topics John Mandrola, MD, covers in this week’s podcast.
  theheart.org on Medscape, August 26, 2022
• Aug 19 2022 This Week in Cardiology   The obesity paradox in AF and paradoxes in general, digital health gets whacked again, and direct-to-consumer ads are the topics discussed by John Mandrola, MD in this week’s podcast.
  theheart.org on Medscape, August 19, 2022